---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-053978"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T21:32:03.678560+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tarsus prices upsized $125M public offering of 2.8M shares at $44.50/share

## Summary
- Offering of 2,808,988 shares at public price $44.50; net proceeds ~$117.1M.
- Upsized from originally proposed $100M; underwriters have 30-day option for additional 421,348 shares.
- Closing expected March 14, 2025; Goldman Sachs, BofA, Barclays, Oppenheimer lead.
- Offering made under effective shelf registration; use of proceeds not specified in filing.

## SEC filing metadata
- accession: 0001193125-25-053978
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000119312525053978/0001193125-25-053978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000119312525053978/d901047d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-053978
- JSON: https://secwatch.observer/filing/0001193125-25-053978.json
- Plain text: https://secwatch.observer/filing/0001193125-25-053978.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.